Home
    • Plans Blog Contact
    Odyssey Health, Inc. logo

    Odyssey Health, Inc.

    ODYY
    Last price US$0.007
    Market cap US$699000.0
    12M price change -70.83%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    Abbott LaboratoriesABT Industry peer DexCom IncDXCM Industry peer Edwards Lifesciences CorpEW Industry peer Zoetis IncZTS Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    Odyssey Health, Inc. Overview

    Industry: Medical Devices

    Sector: Healthcare

    Odyssey Health, Inc., a medical company, focuses on the development and commercialization of medical products. It develops CardioMap, a heart monitoring and screening device; Save A Life choking rescue devices; and PRV-001 and PRV-002 neurosteroid drug compounds to treat concussions and rare brain disorders. The company was formerly known as Odyssey Group International, Inc. Odyssey Health, Inc. was founded in 2014 and is based in Las Vegas, Nevada. Odyssey Health, Inc., a medical company, focuses on the development and commercialization of medical products. It develops CardioMap, a heart monitoring and screening device; Save A Life choking rescue devices; and PRV-001 and PRV-002 neurosteroid drug compounds to treat concussions and rare brain d Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for Odyssey Health, Inc. into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed Jun 12, 2026

    Quarterly result summary

    Latest company-filed earnings material is available for source review.

    What changed

    • Review the SEC source filing for the full reported results and management commentary.

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    SEC filing Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing FORM 10-Q FOR JAN 2026 Mar 12, 2026 SEC filing FORM 10-Q FOR OCT 2025 Dec 11, 2025 SEC filing FORM 10-K FOR JULY 2025 Oct 29, 2025 SEC filing FORM 10-Q FOR APRIL 2025 Jun 13, 2025 SEC filing FORM 10-Q FOR DEC 2024 Mar 14, 2025 SEC filing FORM 10-Q FOR OCTOBER 2024 Dec 16, 2024 SEC filing FORM 10-K FOR JULY 2024 Nov 13, 2024

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    No qualified company news in the last 14 days

    No recent article passed both the company-relevance and source-reliability checks. Research continues to use the other available filings, fundamentals, market data, and valuation inputs.

    Earnings Per Share

    Score 4.00/5
    Odyssey Health, Inc. boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    In Medical Devices industry , Abbott Laboratories , DexCom Inc , Edwards Lifesciences Corp are companies with high ratings.

    Return on Equity

    Score 1.98/5
    Odyssey Health, Inc. exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Odyssey Heal... ODYY US$699000
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Net Margin

    Score 2.21/5
    Odyssey Health, Inc. olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Odyssey Heal... ODYY US$699000
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Share Buyback

    In Medical Devices industry , Abbott Laboratories , DexCom Inc , Edwards Lifesciences Corp are companies with high ratings.

    Leverage

    Score 3.00/5
    Odyssey Health, Inc. attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc , also exhibit high scores.
    Odyssey Heal... ODYY US$699000
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Odyssey Health, Inc. logo

    Odyssey Health, Inc.

    US$0.007

    US$699000.0

    0.00%

    -70.83%